Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland

Dr. Lucas Picavet, PhD
Senior Scientist at Gyes BV
Speaker

Profile

Lucas Picavet, PhD, is Senior Scientist Immunology at Gyes, where he leads multispecific antibody programs in immuno-oncology and autoimmunity. His work focuses on avidity-based design to enable selective and conditional immune cell modulation. Previously, he worked at Genmab on antibody discovery and engineering strategies, and at Gadeta on γδTCR engineered T-cell therapies, optimizing co-stimulation and T-cell persistence. Lucas completed his PhD at the Center for Translational Immunology (Utrecht), studying epigenetic and epitranscriptomic regulation of immune activation in autoimmunity.

Agenda Sessions

  • Avidity Engineering Enables Conditional and Multifunctional Antibody Therapeutics

    11:00